Castle Biosciences (CSTL) has priced its IPO of 4M common shares at $16, for gross proceeds of ~$64M.
The shares are expected to begin trading today on Nasdaq under the symbol “CSTL.”
Closing date is July 29.
Underwriters over-allotment is an additional 0.6M common shares.
Source: Press Release
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.